Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services tags : Alliances save search
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101Patent developed in collaboration with Syngene International Ltd.
Published: 2023-09-26 (Crawled : 13:00) - biospace.com/
PBLA | $0.525 -6.31% 38K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 9.6%
C: 2.4%
sbp-101 patent international collaboration china
BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
Published: 2023-08-14 (Crawled : 13:00) - biospace.com/
AKYA | $3.92 -1.51% -1.53% 180K
|
Professional, Scientific, and T...
|
| O: 0.66%
H: 0.0%
C: -7.58%
TECH | $62.7 -2.05% -2.09% 900K
|
Health Technology
|
| O: -0.83%
H: 1.57%
C: 1.34%
collaboration program
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
Published: 2023-06-29 (Crawled : 14:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.06%
H: 0.3%
C: -0.06%
IRWD | $7.66 -2.92% -3.0% 2.4M
|
Health Technology
|
| O: 0.09%
H: 1.7%
C: 0.76%
ironwood
Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License Agreement
Published: 2023-04-18 (Crawled : 00:00) - biospace.com/
FNCH | $2.5 -19.36% -24.0% 130K
|
Professional, Scientific, and T...
|
| O: -5.18%
H: 7.24%
C: 7.14%
license hospital collaboration therapeutics agreement
ACE-Breast-02 Pivotal Phase 3 Study of Ambrx’s ARX788 for the Treatment of HER2 Positive Metastatic Breast Cancer Achieves Positive Results
Published: 2023-03-01 (Crawled : 14:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: -0.93%
H: 8.16%
C: -7.54%
arx788 treatment breast positive cancer study her2 antibody-as269 metastatic breast cancer
iSpecimen Expands Biospecimen Provider NetworkiSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and Europe
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
ISPC | $0.229 7.97% 7.38% 250K
|
Professional, Scientific, and T...
|
| O: 3.18%
H: 0.55%
C: -2.48%
europe platform
Zentek Signs Distribution Agreement with Southmedic Inc.
Published: 2023-01-19 (Crawled : 15:00) - biospace.com/
ZTEK | $1.14 1.33% 13K
|
Professional, Scientific, and T...
|
| O: 0.68%
H: 1.35%
C: -1.35%
distribution agreement
Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition
Published: 2023-01-06 (Crawled : 14:00) - biospace.com/
ELEV | $4.15 -5.47% -5.78% 500K
|
Professional, Scientific, and T...
|
| O: -6.67%
H: 1.02%
C: -23.47%
eo-3021 ceo
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
Published: 2023-01-06 (Crawled : 14:00) - biospace.com/
AKYA | $3.92 -1.51% -1.53% 180K
|
Professional, Scientific, and T...
|
| O: 0.99%
H: 8.95%
C: 8.41%
A | $134.55 -1.65% -0.85% 2.1M
|
Health Technology
|
| O: 1.48%
H: 0.18%
C: -4.33%
partnership biopharma
Alzamend Neuro Partners With Biorasi to Conduct a First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase I/IIA Clinical Trial
Published: 2023-01-04 (Crawled : 14:00) - biospace.com/
ALZN | $0.7241 -5.01% -5.28% 58K
|
Professional, Scientific, and T...
|
| O: 3.45%
H: 0.0%
C: -3.35%
trial group
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
Published: 2022-12-08 (Crawled : 13:00) - biospace.com/
TRDA | $12.22 -3.93% -4.09% 56K
|
Professional, Scientific, and T...
|
| O: 8.92%
H: 12.12%
C: 8.81%
VRTX | $393.1 -0.27% -0.27% 880K
|
Health Technology
|
| O: -0.01%
H: 2.27%
C: 1.19%
collaboration therapeutics
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
Published: 2022-11-30 (Crawled : 14:00) - biospace.com/
IPA | $1.29 3.88% 59K
|
Professional, Scientific, and T...
|
| O: -0.6%
H: 1.0%
C: -1.19%
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -1.07%
H: 1.62%
C: -3.42%
collaboration license agreement
Day One Announces Cooperative Research and Development Agreement with National Cancer Institute to Expand Development of Tovorafenib (DAY101)
Published: 2022-10-17 (Crawled : 14:00) - biospace.com/
DAWN 4 | $14.87 1.78% 1.75% 800K
|
Professional, Scientific, and T...
|
| O: 2.35%
H: 0.98%
C: -7.96%
day101 day research one agreement cancer
Compass Therapeutics Announces Clinical Collaboration with Merck to Evaluate CTX-471 in Combination with KEYTRUDA® (pembrolizumab)
Published: 2022-10-11 (Crawled : 14:20) - biospace.com/
CMPX | $1.52 -3.19% -3.29% 120K
|
Professional, Scientific, and T...
|
| O: 0.7%
H: 13.64%
C: 8.04%
ctx-471 keytruda collaboration therapeutics
Foundation Medicine and Day One Biopharmaceuticals Announce Global Collaboration to Advance Pediatric Cancer Care
Published: 2022-09-21 (Crawled : 12:00) - biospace.com/
DAWN 4 | $14.87 1.78% 1.75% 800K
|
Professional, Scientific, and T...
|
| O: -0.2%
H: 0.0%
C: -6.82%
day care global collaboration one cancer
BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling
Published: 2022-09-14 (Crawled : 14:20) - biospace.com/
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -0.25%
H: 2.86%
C: 0.75%
sciences life molecular
TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology
Published: 2022-08-02 (Crawled : 17:00) - biospace.com/
RNAZ | $0.5 -0.99% -1.0% 280K
|
Professional, Scientific, and T...
|
| O: 0.14%
H: 4.2%
C: 1.3%
therapeutics
Quoin Pharmaceuticals Announces Licensing and Distribution Agreement with Leading Rare Disease Company for Greater China
Published: 2022-06-15 (Crawled : 14:00) - biospace.com/
QNRX | $0.703 -2.36% -2.42% 37K
|
Professional, Scientific, and T...
|
| O: -2.41%
H: 0.0%
C: -12.49%
rare disease distribution china
Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE™ Molecule
Published: 2022-04-07 (Crawled : 12:00) - biospace.com/
HOWL | $5.84 4.1% 3.94% 410K
|
Professional, Scientific, and T...
|
| O: 6.98%
H: 49.21%
C: 15.42%
JAZZ | News | $107.15 -1.61% -1.63% 590K
|
Health Technology
|
| O: 0.0%
H: 4.11%
C: 3.3%
wtx-613 collaboration license therapeutics
Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
Published: 2022-02-28 (Crawled : 14:00) - biospace.com/
OMIC | $0.38 -2.56% -2.63% 260K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: 0.0%
QGEN | $39.23 -0.23% 0.0% 800K
|
Health Technology
|
| O: 2.78%
H: 1.48%
C: -0.54%
QGEN | $39.23 -0.23% 0.0% 800K
|
Health Technology
|
| O: 2.78%
H: 1.48%
C: -0.54%
genomics genomic platform
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.